Understanding how a mitochondrial protein affects nerve cell repair in the eye

Regulation of the retinal ganglion cell repair program by the mitochondrial protein Armcx1

NIH-funded research Duke University · NIH-11005747

This study is looking at how a special protein helps eye cells called retinal ganglion cells heal and function better, especially when they get damaged, with the hope of finding new ways to help people with vision loss.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University NIH-funded
Lab location1 site (Durham, United States)
Project IDNIH-11005747 on NIH RePORTER

What this research studies

This research investigates the role of a specific mitochondrial protein, Armcx1, in the repair processes of retinal ganglion cells (RGCs), which are crucial for vision. The study aims to uncover how RGCs manage mitochondrial function and distribution, particularly in response to damage. By exploring the mechanisms that regulate mitochondrial transport within these cells, the research seeks to identify potential therapeutic targets for promoting nerve cell repair and regeneration in conditions that lead to vision loss.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from retinal diseases that involve damage to retinal ganglion cells, such as glaucoma or optic neuropathy.

Not a fit: Patients with retinal conditions unrelated to mitochondrial dysfunction or those with advanced vision loss may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance the repair of damaged retinal cells, potentially improving vision for patients with certain eye diseases.

How similar studies have performed: Previous research has shown promising results in enhancing axonal regeneration through mitochondrial transport interventions, suggesting that this approach may be effective.

Where this research is happening

Durham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.